Jean-Emmanuel Kurtz

4PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychiatry (incl. psychotherapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 29, 2023
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.

Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin

|Mar 08, 2023
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.

Nicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley

|Nov 09, 2022
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study.

Simon Nannini, Nicolas Penel, Emmanuelle Bompas

|Jan 07, 2021
Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size.

Laura Bender, Jean-Emmanuel Kurtz, Thierry Petit

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas Penel

1 joint publications

Laura Bender

1 joint publications

Thierry Petit

1 joint publications

Xavier Pivot